Cargando…
Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk‐reducing surgeries in BRCA mutation carriers
BACKGROUND: A higher risk for breast and ovarian cancer has been reported in BRCA carriers and prophylactic surgeries are proposed to reduce this risk. This retrospective cohort study has evaluated the indication of BRCA1/2 genetic tests in Iranian women and the rate of women's acceptance of pr...
Autores principales: | Vasigh, Mahtab, Eslami, Bita, Elahi, Ahmad, Kaviani, Ahmad, Shirkoohi, Reza, Majidzadeh, Keivan, Nazarian, Newsha, Omranipour, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830810/ https://www.ncbi.nlm.nih.gov/pubmed/35023322 http://dx.doi.org/10.1002/mgg3.1867 |
Ejemplares similares
-
Evaluation of HER2 Positivity Based on Clinicopathological Findings in HER2 Borderline Tumors in Iranian Patients with Breast Cancer
por: Omranipour, Ramesh, et al.
Publicado: (2023) -
In silico analysis for determining the deleterious nonsynonymous single nucleotide polymorphisms of BRCA genes
por: Yadegari, Fatemeh, et al.
Publicado: (2019) -
Mutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer
por: Zorrieh Zahra, Atieh, et al.
Publicado: (2016) -
Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers
por: Hughes, L, et al.
Publicado: (2008) -
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)